With a single opinion from the U.S. Court of Appeals for the Federal Circuit, fraud just became more difficult to prove as part of the trademark application process. This week, the Federal Circuit released its long-awaited opinion in In re Bose Corp., Docket No. 2008-1448 (Fed. Cir. 2009) reversing the Trademark Trial and Appeal Board’s controversial Medinol standard for findings of fraud.
Click on the PDF link above to view the full alert.